Chicago, ILNCT06176833Now EnrollingIRB Ready

Spinal Cord Injuries Clinical Trial in Chicago, IL

Access cutting-edge spinal cord injuries treatment through this clinical trial at a research site in Chicago. Study-provided care at no cost to qualified participants.

Sponsored by Milap Sandhu

Quick Self-Assessment

See if you qualify for this Chicago location

Preparing your pre-screening questions…

Expert Care in Chicago

Access spinal cord injuries specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related spinal cord injuries treatment provided free

Apply for This Chicago Location

Check if you qualify for this spinal cord injuries clinical trial in Chicago, IL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Chicago

    Convenient for IL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Chicago site if eligible
  4. 4Begin participation

About This Spinal Cord Injuries Study in Chicago

The purpose of this study is to evaluate if a specific type of additional walking therapy, called body weight supported treadmill training (BWSTT) affects walking ability following a traumatic spinal cord injury. Specifically, the study will look at whether starting BWSTT, which uses a body harness to support body weight while walking on a treadmill at different times within the first 6 months after the injury, makes a difference in how effective this therapy may be, While we know that the brain re-learns patterns following an injury, there has not been a lot of prior research evaluating how starting this type of walking therapy at specific times within the first 6 months after injury may impact any effectiveness of the additional therapy. The study will randomize participants into four groups: those who start this therapy within 60 days, within 3 months, within 6 months or who do not receive this additional research therapy. Randomization means that which group you will be in as part of this study is determined by chance, like the flip of a coin. The additional walking therapy for this research study, if you are randomized for one of the three groups who receives the additional therapy, will be given on top of (meaning in addition to) any standard of care therapies that you may be receiving at that time point after your injury.

Sponsor: Milap Sandhu

Who Can Participate

Inclusion Criteria

History of Acute and Traumatic SCI with AIS classification of B, C, or D between the neurological levels of C5 and T12
Between the ages of 16-74
Weight bearing as tolerated in bilateral lower extremities
Able to tolerate a harness
Ability to provide informed consent. For minors, consent of parents or primary caregivers/guardians and assent of the minor
Able to provide informed consent within 60 days of injury onset
Able to participate in all study related activities, including 1-year follow up

Exclusion Criteria

Orthopedic injuries, fractures, surgeries, or other conditions affecting locomotor function or weight bearing
A weight over 250lbs and if so a BMI greater than 30, or deemed clinically inappropriate due to body habitus
Moderate to sever traumatic brain injury of other neurological conditions at a severity which impairs cognition
Presence of uncontrolled orthostatic hypotension that limits active participation in intense physical rehabilitation program.
Other medical complications such as severe heart failure or large/deep pelvic or lower abdominal wounds that may limit the ability to safely don and doff a harness for ambulation
Pregnancy, as confirmed by blood draw

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Chicago?

Yes, this clinical trial (NCT06176833) has an active research site in Chicago, IL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Spinal Cord Injuries Treatment Options in Chicago, IL

If you're searching for spinal cord injuries treatment options in Chicago, IL, this clinical trial (NCT06176833) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Chicago research site is actively enrolling participants for this clinical trial. You'll receive care from experienced spinal cord injuries specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Ready to Join in Chicago?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Chicago, IL